Peptide receptor radionuclide therapy (PRRT)

Peptide receptor radionuclide therapy (PRRT) is a targeted cancer treatment that uses radioactive substances attached to small proteins called peptides. These peptides are designed to bind to specific receptors found on certain cancer cells, particularly neuroendocrine tumors. Once the peptides attach to the tumor cells, the radioactive component delivers localized radiation, damaging the cancer cells while sparing surrounding healthy tissue. PRRT can help shrink tumors, reduce symptoms, and potentially improve survival in patients with these types of cancer. It represents a personalized approach, leveraging the unique biology of the tumors to enhance treatment effectiveness.